SESSA, Rosa
 Distribuzione geografica
Continente #
NA - Nord America 4.353
EU - Europa 1.226
AS - Asia 770
AF - Africa 40
SA - Sud America 38
OC - Oceania 2
Totale 6.429
Nazione #
US - Stati Uniti d'America 4.323
IT - Italia 466
SG - Singapore 284
IN - India 217
CN - Cina 208
FI - Finlandia 159
SE - Svezia 130
UA - Ucraina 112
DE - Germania 100
GB - Regno Unito 61
NL - Olanda 39
ID - Indonesia 38
TG - Togo 32
BG - Bulgaria 30
IE - Irlanda 28
AR - Argentina 27
FR - Francia 25
CA - Canada 24
RU - Federazione Russa 23
BE - Belgio 14
PL - Polonia 8
BR - Brasile 7
ES - Italia 6
RO - Romania 6
MX - Messico 5
CH - Svizzera 4
JP - Giappone 4
TH - Thailandia 4
ZA - Sudafrica 4
AT - Austria 3
EC - Ecuador 3
NO - Norvegia 3
TR - Turchia 3
AE - Emirati Arabi Uniti 2
HR - Croazia 2
IR - Iran 2
KR - Corea 2
LT - Lituania 2
PT - Portogallo 2
SC - Seychelles 2
AL - Albania 1
AU - Australia 1
AZ - Azerbaigian 1
DK - Danimarca 1
HK - Hong Kong 1
IL - Israele 1
LV - Lettonia 1
MA - Marocco 1
NG - Nigeria 1
NZ - Nuova Zelanda 1
PA - Panama 1
PE - Perù 1
PK - Pakistan 1
TM - Turkmenistan 1
VN - Vietnam 1
Totale 6.429
Città #
Fairfield 578
Chandler 403
Ashburn 336
Seattle 251
Houston 249
Woodbridge 240
Singapore 211
Rome 207
Dearborn 195
Cambridge 188
Ann Arbor 181
Wilmington 174
Princeton 111
New York 109
Santa Clara 101
Beijing 93
Plano 91
Lawrence 76
Helsinki 73
San Paolo di Civitate 64
Boston 58
San Diego 53
Millbury 42
Jacksonville 39
Andover 38
Jakarta 37
Lomé 32
Sofia 30
Maastricht 27
Boardman 26
Federal 26
Fremont 25
Dublin 23
San Mateo 21
Norwalk 19
Bremen 17
Falkenstein 17
Civitavecchia 16
Milan 16
Toronto 15
Des Moines 14
Hefei 13
Nanjing 13
Stockholm 13
Moscow 12
Brussels 11
London 10
Los Angeles 9
Munich 9
Phoenix 9
Falls Church 8
Ottawa 8
Southend 7
Bühl 6
Chicago 6
Lenola 6
Pune 6
Chengdu 5
Guangzhou 5
Kunming 5
Lappeenranta 5
Mannheim 5
Menlo Park 5
Philadelphia 5
Bangkok 4
Brooklyn 4
Buffalo 4
Hangzhou 4
Nanchang 4
San Francisco 4
Warsaw 4
Washington 4
Altamura 3
Amsterdam 3
Bartlesville 3
Centallo 3
Colombes 3
Frankfurt am Main 3
Jinan 3
Lanciano 3
Latina 3
Lille 3
Oslo 3
Palermo 3
Redmond 3
Shanghai 3
Shenyang 3
Verona 3
Xian 3
Albany 2
Aurangabad 2
Aversa 2
Bern 2
Brugherio 2
Castelgomberto 2
Castelnuovo di Porto 2
Catania 2
Cura 2
Dąbrowa Górnicza 2
Eagan 2
Totale 4.808
Nome #
A simple, fast and reliable scan-based technique as a novel approach to quantify intracellular bacteria 123
Infectious burden and atherosclerosis. A clinical issue 120
Lactobacilli-lactoferrin interplay in Chlamydia trachomatis infection 111
Biofilm in genital ecosystem: a potential risk factor for Chlamydia trachomatis infection. 108
Chlamydia pneumoniae-mediated inflammation in atherosclerosis: a meta-analysis. 103
Burkholderia cenocepacia vaginal infection in patient with smoldering myeloma and chronic hepatitis C 99
Chlamydia pneumoniae clinical isolate from gingival crevicular fluid. A potential atherogenic strain 98
Analysis of gene expression in penicillin G induced persistence of Chlamydia pneumoniae 94
Effects of Mentha suaveolens essential oil on C. trachomatis 90
Chlamydia pneumoniae infection is associated with coronary artery disease but not implicated in inducing plaque instability 89
Chlamydia pneumoniae in asymptomatic carotid atherosclerosis 87
Detection of Borrelia burgdorferi sensu lato DNA by PCR in serum of patients with clinical symptoms of Lyme borreliosis. 86
Chlamydia pneumoniae in PBMC: Reproducibility of the OMPA nested touchdown PCR 85
Apyrase, the product of the virulence plasmid-encoded phoN2 (apy) gene of Shigella flexneri, is necessary for proper unipolar IcsA localization and for efficient intercellular spread 85
Chlamydia pneumoniae and oxidative stress in cardiovascular disease. State of the art and prevention strategies. 84
Diversity of cervical microbiota in asymptomatic chlamydia trachomatis genital infection: a pilot study 84
Chlamydia trachomatis elicits TLR3 expression but disrupts the inflammatory signaling down-modulating NFκB and IRF3 transcription factors in human Sertoli cells 83
CHLAMYDIA PNEUMONIAE AND ATHEROSCLEROSIS: CURRENT STATE AND FUTURE PROSPECTIVES 82
Chlamydia pneumoniae as risk factor of cardiovascular disease in dialysis patients 81
Chlamydia pneumoniae infection in atherosclerotic lesion development through oxidative stress: A brief overview 81
Chlamydia pneumoniae and chronic diseases with a great impact on public health 81
Borrelia burgdorferi s.l. and Ehrlichia chaffeensis in the National Park of Abruzzo 81
Antibacterial activity and impact of different antiseptics on biofilm-contaminated implant surfaces 81
Effect of amino acid starvation on glucose transport in two archaeal organisms 80
Growth kinetics of Chlamydia trachomatis in primary human Sertoli cells 79
Selected immunological mediators and cervical microbial signatures in women with chlamydia trachomatis infection 79
Molecular characterization of Burkholderia cepacia isolates from cystic fibrosis (CF) patients in an Italian CF center 79
Detection of different borrelia Burgdorferi genospecies in serum of people with different occupational risks: Short report 77
Chlamydia pneumoniae DNA in patients with symptomatic carotid atherosclerotic disease 77
Interferon-γ possesses anti-microbial and immunomodulatory activity on a Chlamydia Trachomatis infection model of primary human synovial fibroblasts 75
Characterization of the vaginal microbiota in Italian women with endometriosis. Preliminary study 73
Chlamydia pneumoniae infection and atherosclerotic coronary disease 73
Agenti infettivi nella patogenesi della cardiopatia ischemica 72
Melaleuca alternifolia essential oil possesses potent anti-staphylococcal activity extended to strains resistant to antibiotics 72
Chlamydia trachomatis and Chlamydia pneumoniae Interaction with the Host. Latest advances and future prospective. 72
Could Chlamydia pneumoniae be considered an infectious risk factor for inflammatory diseases such as atherosclerosis? 71
Stringent control in the archaeal genus Sulfolobus 71
Real time PCR for detection of Chlamydophila pneumoniae in peripheral blood mononuclear cells of patients with multiple sclerosis 67
[Chlamydia pneumoniae infection and cardiac ischemic syndromes]. 67
What is the Hidden Biological Mechanism Underlying the Possible SARS-CoV-2 Vertical Transmission? A Mini Review 67
Effects of vaginal lactobacilli in Chlamydia trachomatis infection 66
Detection of Chlamydia pneumoniae in atherosclerotic coronary arteries 65
The elusive but pathogenic peptidoglycan of chlamydiae 64
In vitro modelling of Chlamydia trachomatis infection in the Etiopathogenesis of male infertility and reactive arthritis 64
Epidemiology of urogenital infections caused by Chlamydia trachomatis and outline of characteristic features of patients at risk. 62
Chlamydia pneumoniae and osteoporosis-associated bone loss: A new risk factor? 62
No evidence of involvement of Chlamydia pneumoniae in lung cancer by means of quantitative real-time polymerase chain reaction 62
Prevalence of Clamydia pneumoniae in peripheral blood mononuclear cells in italian patients with acute ischaemic heart disease 62
Multicentric study of seroprevalence of Borrelia burgdorferi and anaplasma phagocytophila in high-risk groups in regions of central and southern Italy 61
Lyme borreliosis infection in Europe. 61
Evaluation of neutrophil CD64 expression and procalcitonin as useful markers in early diagnosis of sepsis 61
Lack of association of Chlamydia pneumoniae with cardiovascular diseases in virologically suppressed HIV patients 61
Prevalence of IgG antibodies against Borrelia burgdorferi SL and Ehrlichia phagocytophila in sera of patients presenting symptoms of Lyme disease in a central region of Italy 60
Effect of bovine lactoferrin on chlamydia trachomatis infection and inflammation. 59
ASPETTI MOLECOLARI DELLA FORMA PERSISTENTE DI CHLAMYDIA PNEUMONIAE 58
CHLAMYDIA PNEUMONIAE AND ATHEROSCLEROSIS: THE ROLE OF MAST CELLS 56
Infectious agents in atherosclerotic cardiovascular diseases through oxidative stress 56
Bacterial anti-Ig activity. 54
Human colonic myogenic dysfunction induced by mucosal lipopolysaccharide translocation and oxidative stress 54
In vitro susceptibility of isolates of Borrelia burgdorferi s.l. to antimicrobial agents 53
New insights into Chlamydiae persistence: An energy metabolism strategy? 53
Extra virgin olive oil-based green formulations with promising antimicrobial activity against drug-resistant isolates 53
CUTANEOUS INFECTION OF NOCARDIA ALTAMIRENSIS: THE FIRST CASE REPORT 52
Biofilm formation on the surface of ceramic tiles 52
Genotyping of different Pseudomonas aeruginosa morphotypes arising from the lower respiratory tract of a patient taken to an Intensive Care Unit 51
HPV/Chlamydia trachomatis co-infection. Metagenomic analysis of cervical microbiota in asymptomatic women 51
Determination of antibodies to Borrelia burgdorferi in the serum of patients living in Calabria, Southern Italy 50
Detection of four Borrelia burgdorferi genospecies and first report of human granulocytic ehrlichiosis agent in Ixodes ricinus ticks collected in central Italy 50
Chlamydia pneumoniae induces T cell apoptosis through glutathione redox imbalance and secretion of TNF-alpha. 50
Measurement of Chlamydia pneumoniae bacterial load in peripheral blood mononuclear cells may be helpful to assess the state of chlamydial infection in patients with carotid atherosclerotic disease 50
Chlamydia pneumoniae infection in patients with acute coronary syndrome: A clinical and serological 1-year follow-up 49
[Infective agents in the pathogenesis of ischemic cardiopathy]. 46
CHLAMYDIA TRACHOMATIS INFECTION IN OBSTETRICS AND GYNAECOLOGY; THE ITALIAN EXPERIENCE 46
Chlamydiae. Nota II: Chlamydia trachomatis. 45
Therapeutic potential of resveratrol against emerging respiratory viral infections 45
Potential IFNγ modulation of inflammasome pathway in Chlamydia trachomatis infected synovial cells 45
Evaluation by real-time PCR of the expression of S. flexneri virulence-associated genes ospB and phoN2 under different genetical background 44
In-cell western assay as a high-throughput approach for Chlamydia trachomatis quantification and susceptibility testing to antimicrobials 44
In vivo and in vitro assessment of the virulence of Listeria monocytogenes strains 44
RESVERATROL IN CHLAMYDIA PNEUMONIAE-INDUCED FOAM CELL FORMATION AND INTERLEUKIN-17A SYNTHESIS 42
Ruolo dell’infezione da Chlamydia pneumoniae in pazienti con angina instabile 42
Oxidative Stress and Inflammation in SARS-CoV-2- and Chlamydia pneumoniae-Associated Cardiovascular Diseases 42
The potential role of hypochlorhydria in the development of duodenal dysbiosis. A preliminary report 42
SARS-CoV-2 infection in pregnancy. Clues and proof of adverse outcomes 41
the link between Clamydia pneumoniae infection and abdominal aortic aneurysms: a problem still to solve. 41
EPIDEMIOLOGICAL AND THERAPEUTICAL OBSERVATIONS ON CHLAMYDIA TRACHOMATIS INFECTIONS IN GYNECOLOGICAL PATIENTS IN ROME 41
AP-PCR typing of Pseudomonas aeruginosa isolated from patients with cystic fibrosis 41
The major epidemic infections: A gift from the old world to the new? 40
Towards a Deeper Understanding of Chlamydia trachomatis Pathogenetic Mechanisms: Editorial to the Special Issue “Chlamydia trachomatis Pathogenicity and Disease” 40
SARS-CoV-2 vertical transmission in a twin-pregnant woman. A case report 39
Chlamydiae. Nota I. 39
Extra virgin olive oil-based formulations. A "green" strategy against Chlamydia trachomatis 38
Ruolo dell’infezione da Chlamydia Pneumoniae nella cardiopatia ischemica giovanile 38
Could past Chlamydial vascular infection promote the dissemination of Chlamydia pneumoniae to the brain? 37
Lyme borreliosis in Central Italy (1995-1998) 36
CHLAMYDIA PNEUMONIAE INFECTION AS A RISK FACTOR FOR ACCELERATED ATHEROSCLEROSIS IN HEMODIALYSIS PATIENTS 36
Clinical and Epidemiological Observations on Chlamydia Trachomatis infections 36
Impact of air pollution on the composition and diversity of human gut microbiota in general and vulnerable populations. A systematic review 35
Effect of bovine serum, hyaluronic acid and netilmicine on the in vitro adhesion of bacteria isolated from human-worn disposable soft contact lenses. 33
RESISTANCE SURVELLANCE IN ITALY: FOUR-YEAR RESULTS FROM THE MYSTIC PROGRAM 31
Totale 6.298
Categoria #
all - tutte 22.155
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 22.155


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2019/2020715 0 0 0 0 0 0 195 159 128 133 67 33
2020/2021461 47 38 40 40 27 37 8 50 67 54 33 20
2021/20221.195 17 67 89 48 128 14 17 113 94 92 303 213
2022/20231.231 203 279 53 161 123 103 15 86 125 14 33 36
2023/2024798 37 94 32 78 50 200 20 86 3 59 67 72
2024/2025681 68 110 85 125 114 174 5 0 0 0 0 0
Totale 6.744